Phillip Wong
Memorial Sloan Kettering Cancer Center(US)University of Toronto(CA)Hudson Institute of Medical Research(AU)Princess Margaret Cancer Centre(CA)Kettering University(US)Monash Health(AU)Indiana University – Purdue University Indianapolis(US)Monash University(AU)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Melanoma and MAPK Pathways, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,864 cited
- → Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma(2014)4,353 cited
- → In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens(2002)1,725 cited
- → T-cell invigoration to tumour burden ratio associated with anti-PD-1 response(2017)1,620 cited
- → Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus(1998)655 cited
- → Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab(2016)540 cited